2nd Quarter - Report

RK STRATEGIES, INC. for RECCE PHARMACEUTICALS LTD

Period 2nd Quarter 2026 Filed Jul 18, 2026 Signed by Ryan Kane

Official filing
Firm
RK STRATEGIES, INC.
Client
RECCE PHARMACEUTICALS LTD
Income
$20,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General healthcare/wound care issues Pandemic and All Hazards Preparedness Act Reauthorization Appropriations Issues

Foreign entity interest: Recce Pharmaceuticals Inc is principally located in Sydney, Australia

LobbyistCovered position, as disclosed
RYAN KANE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Defense Threat Reduction Agency (DTRA)

Defense DEF

General biodefense/wound care issues Pandemic and All Hazards Preparedness Act Reauthorization Other Appropriations Issues Related to Wound Care/Biodefense

Foreign entity interest: Recce Pharmaceuticals Inc is principally located in Sydney, Australia

LobbyistCovered position, as disclosed
RYAN KANE —

Contacted: Defense, Dept of (DOD); SENATE; HOUSE OF REPRESENTATIVES

Veterans VET

General wound care issues

Foreign entity interest: Recce Pharmaceuticals Inc is principally located in Sydney, Australia

LobbyistCovered position, as disclosed
RYAN KANE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.